Enrollment open • Tumor mutational burden • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • CD4 (CD4 Molecule) • TGFBI (Transforming Growth Factor Beta Induced)
|
HER-2 negative
|
gemcitabine • Danyelza (naxitamab-gqgk) • UD TGFbetai NK cells